NL-OMON32534招募中不适用
Determinants of insulin-induced weight gain in patients with type 2 diabetes mellitus, a prospective study on body compostion, physical activity and metabolic markers - determinants of insulin-induced weight gain in type 2 diabetes mellitus
niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 180 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients with type 2 diabetes mellitus who will start with insulin therapy
- •Age 18-85 years
- •Baseline HbA1c < 12.0%
- •Written informed consent
排除标准
- •Clinical evidence of psychiatric, renal, cardiovascular or liver or other diseases which may influence study results regarding glucose and weight.
- •Patients with hormonal disorders which may influence weight (i.e. thyroid diseases), unless properly treated with stable hormonal levels.
- •Excessive alcohol consumption (>20 g/day), and drug abuse
- •Use of thiazolidinedione derivatives (TZDs)
- •Pregnancy or intention to become pregnant during the study
研究者
相似试验
尚未招募
不适用
Determinants of insulin-induced weight gain in patients with type 2 diabetes mellitus, a study on liver fat content, physical activity and metabolic markers comparing weight gainers vs. non-weight gainersNL-OMON31007niversitair Medisch Centrum Sint Radboud40
已完成
不适用
Insulin-induced weight gain in type 2 diabetestype 2 diabetesWeight gainMetabolic and Endocrine - DiabetesDiet and Nutrition - ObesityACTRN12615000462583Melbourne Health340
已完成
不适用
Insulin Detemir Compared to Insulin Glargine: Appetite and Calories Consumed in Type 1 DiabetesDiabetes MellitusNCT00659165University of New Mexico10
Unknown
不适用
Determinants of Insulin-induced Weight Gain in Type 2 Diabetes MellitusWeight GainType 2 Diabetes MellitusNCT00781495Radboud University Medical Center75
已完成
不适用
Studies of insulin action in patients at increased vascular risk: modulation by anti-hypertensive and endocrine replacement therapyHypertension, type two diabetes, hypopituitarismNutritional, Metabolic, EndocrineHypertensionISRCTN84921696Royal Group Hospitals Trust (UK)45